Morgan Stanley analyst Drew Ranieri maintains $Stryker Corp (SYK.US)$ with a hold rating, and adjusts the target price from $350 to $370.
According to TipRanks data, the analyst has a success rate of 37.7% and a total average return of -6.0% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Stryker Corp (SYK.US)$'s main analysts recently are as follows:
Stryker's recent financial results demonstrated a notable outperformance, characterized by 11.5% organic growth, robust double-digit expansion in the majority of its key businesses, and a higher than anticipated operating margin.
Stryker's Q3 outcomes surpassed expectations, showcasing double-digit growth in both revenue and earnings, in conjunction with an increase in operating margins.
Stryker's recent financial results showed a stronger than expected performance on the revenue front. Looking ahead to 2025, the company's growth is anticipated to be fueled by the introduction of new products, the positive impact from mergers and acquisitions with an estimated 7 deals in the pipeline contributing to growth, and the ongoing increase in utilization of Mako, particularly with the addition of two new indications. The analyst indicates maintaining a cautious stance until there is more certainty in sales and earnings per share surpassing market expectations.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
摩根士丹利分析師Drew Ranieri維持$史賽克 (SYK.US)$持有評級，並將目標價從350美元上調至370美元。
根據TipRanks數據顯示，該分析師近一年總勝率為37.7%，總平均回報率為-6.0%。
此外，綜合報道，$史賽克 (SYK.US)$近期主要分析師觀點如下：
Stryker最近的財務業績顯示出明顯的跑贏大盤，其特點是11.5％的有機增長，其大多數關鍵業務實現了強勁的兩位數擴張，營業利潤率高於預期。
Stryker的第三季度業績超出了預期，收入和收益均實現了兩位數的增長，同時營業利潤率也有所提高。
Stryker最近的財務業績顯示，收入方面的表現強於預期。展望2025年，預計該公司的增長將受到新產品的推出、合併和收購的積極影響（估計有7筆交易在進行中）推動增長，以及Mako利用率的持續提高，尤其是增加了兩個新適應症。分析師表示，在銷售額和每股收益超過市場預期的確定性之前，將保持謹慎立場。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
